Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria

Ana Giménez-Arnau, Silvia Ferrucci, Moshe Ben-Shoshan, Vincent Mikol, Laurence Lucats, Iris Sun, Leda Mannent, Jessica Gereige

Open source

DOI
10.1001/jamadermatol.2025.0733
Published
2025-07-01
Container
JAMA Dermatology
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2025.0733,
  title = {Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria},
  author = {Ana Giménez-Arnau and Silvia Ferrucci and Moshe Ben-Shoshan and Vincent Mikol and Laurence Lucats and Iris Sun and Leda Mannent and Jessica Gereige},
  year = {2025},
  journal = {JAMA Dermatology},
  doi = {10.1001/jamadermatol.2025.0733},
  url = {https://doi.org/10.1001/jamadermatol.2025.0733}
}

RIS

TY  - JOUR
TI  - Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria
AU  - Ana Giménez-Arnau
AU  - Silvia Ferrucci
AU  - Moshe Ben-Shoshan
AU  - Vincent Mikol
AU  - Laurence Lucats
AU  - Iris Sun
AU  - Leda Mannent
AU  - Jessica Gereige
PY  - 2025
JO  - JAMA Dermatology
DO  - 10.1001/jamadermatol.2025.0733
UR  - https://doi.org/10.1001/jamadermatol.2025.0733
ER  - 

APA

Giménez-Arnau, A., Ferrucci, S., Ben-Shoshan, M., Mikol, V., Lucats, L., Sun, I., Mannent, L., & Gereige, J. (2025). Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2025.0733

Source records